‹ All Posts
FnO Tattva

26th May 2025 · SEBI-Registered Analyst

AUROBINDO PHARMA

AUROPHARMA
Net Profit up 0.5% At ₹902.8 Cr Vs ₹907.40 Cr (YoY) Revenue up 10.6% At ₹8,382.1 Cr Vs ₹7,580.14 Cr (YoY) EBITDA up 7.1% At ₹1,792 Cr Vs ₹1,672.80 Cr (YoY) Margin At 21.38% Vs 22.10% (YoY)

#WatchOutFor#StockInNews#TechnicalViews#FundamentalViews#Miscellaneous
125 likes·80 comments